NS 11394
Selleck Chemicals
SKU:S6755-5MG
Couldn't load pickup availability

NS 11394 is a modulator of GABA Receptors used in studies of Neurotransmission. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to synaptic signaling, receptor activity, and neuronal excitability in neuroscience models.
By modulating GABA Receptors, NS 11394 can be used to examine synaptic signaling, receptor activity, and neuronal excitability. This context is compatible with electrophysiology, neurotransmission, and receptor-response assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving GABA Receptors
- Pathway perturbation studies connected to Neurotransmission
- Context-dependent response profiling and mechanism comparison
- Phenotypic profiling in neuroscience models
Overall, NS 11394 is appropriate when a defined chemical perturbant is needed to connect GABA Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- GABA Receptors
- Target Class:
- Other
- Pathways:
- Neurotransmission
- Research Area:
- Neuroscience
- CAS No.:
- 951650-22-9
- Molecular Weight:
- 353.42
- Formula:
- C₂₃H₁₉N₃O
- SMILES:
- CC(C)(C1=CC2=C(C=C1)N(C=N2)C3=CC=CC(=C3)C4=CC=CC=C4C#N)O
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.